Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
about
Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patientsInhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogueSomatostatin and the dumping syndrome.Medical treatment of gastroenteropancreatic neuroendocrine tumors.What is the cause of the carcinoid flush?Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel).
P2860
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
description
1981 nî lūn-bûn
@nan
1981 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@ast
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@en
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@nl
type
label
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@ast
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@en
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@nl
prefLabel
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@ast
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@en
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@nl
P2093
P2860
P356
P1433
P1476
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
@en
P2093
Grahame-Smith DG
P2860
P304
P356
10.1136/GUT.22.7.549
P407
P577
1981-07-01T00:00:00Z